<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;ff=20240508180802&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;ff=20240508180802&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 08 May 2024 22:08:03 +0000</lastbuilddate>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Underrepresentation of Women in Revascularization Trials</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38717765/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 8. doi: 10.1001/jamacardio.2024.0768. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38717765/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38717765</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0768>10.1001/jamacardio.2024.0768</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38717765</guid>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Celina M Yong</dc:creator>
<dc:creator>William F Fearon</dc:creator>
<dc:date>2024-05-08</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Underrepresentation of Women in Revascularization Trials</dc:title>
<dc:identifier>pmid:38717765</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0768</dc:identifier>
</item>
<item>
<title>Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38717753/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: HBR status is prevalent among older patients with MI, significantly increasing the likelihood of adverse events. Physiology-guided complete revascularization emerges as an effective strategy, in comparison with culprit-only revascularization, for mitigating ischemic adverse events, including cardiovascular death and MI.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 8. doi: 10.1001/jamacardio.2024.0804. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Patients with high bleeding risk (HBR) have a poor prognosis, and it is not known if they may benefit from complete revascularization after myocardial infarction (MI).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To investigate the benefit of physiology-guided complete revascularization vs a culprit-only strategy in patients with HBR, MI, and multivessel disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This was a prespecified analysis of the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) randomized clinical trial data. FIRE was an investigator-initiated, open-label, multicenter trial. Patients 75 years or older with MI and multivessel disease were enrolled at 34 European centers from July 2019 through October 2021. Physiology treatment was performed either by angiography- or wire-based assessment. Patients were divided into HBR or non-HBR categories in accordance with the Academic Research Consortium HBR document.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: Patients were randomized to either physiology-guided complete revascularization or culprit-only strategy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary outcome comprised a composite of death, MI, stroke, or revascularization at 1 year. Secondary outcomes included a composite of cardiovascular death or MI and Bleeding Academic Research Consortium (BARC) types 3 to 5.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 1445 patients (mean [SD] age, 81 [5] years; 917 male [63%]), 1025 (71%) met HBR criteria. Patients with HBR were at higher risk for the primary end point (hazard ratio [HR], 2.01; 95% CI, 1.47-2.76), cardiovascular death or MI (HR, 1.89; 95% CI, 1.26-2.83), and BARC types 3 to 5 (HR, 3.28; 95% CI, 1.40-7.64). The primary end point was significantly reduced with physiology-guided complete revascularization as compared with culprit-only strategy in patients with HBR (HR, 0.73; 95% CI, 0.55-0.96). No indication of interaction was noted between revascularization strategy and HBR status for primary and secondary end points.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: HBR status is prevalent among older patients with MI, significantly increasing the likelihood of adverse events. Physiology-guided complete revascularization emerges as an effective strategy, in comparison with culprit-only revascularization, for mitigating ischemic adverse events, including cardiovascular death and MI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03772743.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38717753/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38717753</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0804>10.1001/jamacardio.2024.0804</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38717753</guid>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Andrea Erriquez</dc:creator>
<dc:creator>Gianluca Campo</dc:creator>
<dc:creator>Vincenzo Guiducci</dc:creator>
<dc:creator>Javier Escaned</dc:creator>
<dc:creator>Raul Moreno</dc:creator>
<dc:creator>Gianni Casella</dc:creator>
<dc:creator>Mila Menozzi</dc:creator>
<dc:creator>Enrico Cerrato</dc:creator>
<dc:creator>Giorgio Sacchetta</dc:creator>
<dc:creator>Alberto Menozzi</dc:creator>
<dc:creator>Ignacio Amat Santos</dc:creator>
<dc:creator>Enrique Gutiérrez Ibañes</dc:creator>
<dc:creator>Roberto Scarsini</dc:creator>
<dc:creator>Giuseppe Vadalà</dc:creator>
<dc:creator>Giuseppe Andò</dc:creator>
<dc:creator>José Luis Díez-Gil</dc:creator>
<dc:creator>Sergio Musto d'Amore</dc:creator>
<dc:creator>Alessandro Capecchi</dc:creator>
<dc:creator>Iginio Colaiori</dc:creator>
<dc:creator>Francesco Gallo</dc:creator>
<dc:creator>Rita Pavasini</dc:creator>
<dc:creator>Andrea Marrone</dc:creator>
<dc:creator>Graziella Pompei</dc:creator>
<dc:creator>Valerio Lanzilotti</dc:creator>
<dc:creator>Dariusz Dudek</dc:creator>
<dc:creator>Emanuele Barbato</dc:creator>
<dc:creator>Matteo Tebaldi</dc:creator>
<dc:creator>Simone Biscaglia</dc:creator>
<dc:date>2024-05-08</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:38717753</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0804</dc:identifier>
</item>
<item>
<title>Error in Table 1</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38717750/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 8. doi: 10.1001/jamacardio.2024.1123. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38717750/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38717750</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.1123>10.1001/jamacardio.2024.1123</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38717750</guid>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-08</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Error in Table 1</dc:title>
<dc:identifier>pmid:38717750</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.1123</dc:identifier>
</item>
<item>
<title>Cardiac biomarkers for diagnosing Takotsubo syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38717630/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 8:ehae231. doi: 10.1093/eurheartj/ehae231. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38717630/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38717630</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae231>10.1093/eurheartj/ehae231</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38717630</guid>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Victor Schweiger</dc:creator>
<dc:creator>Davide Di Vece</dc:creator>
<dc:creator>Victoria L Cammann</dc:creator>
<dc:creator>Iva Koleva</dc:creator>
<dc:creator>Michael Würdinger</dc:creator>
<dc:creator>Thomas Gilhofer</dc:creator>
<dc:creator>Katja Rajman</dc:creator>
<dc:creator>Konrad A Szawan</dc:creator>
<dc:creator>David Niederseer</dc:creator>
<dc:creator>Rodolfo Citro</dc:creator>
<dc:creator>Carmine Vecchione</dc:creator>
<dc:creator>Eduardo Bossone</dc:creator>
<dc:creator>Sebastiano Gili</dc:creator>
<dc:creator>Michael Neuhaus</dc:creator>
<dc:creator>Jennifer Franke</dc:creator>
<dc:creator>Benjamin Meder</dc:creator>
<dc:creator>Miłosz Jaguszewski</dc:creator>
<dc:creator>Michel Noutsias</dc:creator>
<dc:creator>Maike Knorr</dc:creator>
<dc:creator>Thomas Jansen</dc:creator>
<dc:creator>Fabrizio D'Ascenzo</dc:creator>
<dc:creator>Francesco Bruno</dc:creator>
<dc:creator>Ovidio De Filippo</dc:creator>
<dc:creator>Giulio Stefanini</dc:creator>
<dc:creator>Gianluca Campo</dc:creator>
<dc:creator>Wojciech Wanha</dc:creator>
<dc:creator>Sergio Raposeiras Roubin</dc:creator>
<dc:creator>Wolfgang Dichtl</dc:creator>
<dc:creator>Dirk von Lewinski</dc:creator>
<dc:creator>Christof Burgdorf</dc:creator>
<dc:creator>Behrouz Kherad</dc:creator>
<dc:creator>Carsten Tschöpe</dc:creator>
<dc:creator>Annahita Sarcon</dc:creator>
<dc:creator>Jerold Shinbane</dc:creator>
<dc:creator>Lawrence Rajan</dc:creator>
<dc:creator>Guido Michels</dc:creator>
<dc:creator>Roman Pfister</dc:creator>
<dc:creator>Alessandro Cuneo</dc:creator>
<dc:creator>Claudius Jacobshagen</dc:creator>
<dc:creator>Mahir Karakas</dc:creator>
<dc:creator>Wolfgang Koenig</dc:creator>
<dc:creator>Alexander Pott</dc:creator>
<dc:creator>Philippe Meyer</dc:creator>
<dc:creator>Marco Roffi</dc:creator>
<dc:creator>Adrian Banning</dc:creator>
<dc:creator>Mathias Wolfrum</dc:creator>
<dc:creator>Florim Cuculi</dc:creator>
<dc:creator>Richard Kobza</dc:creator>
<dc:creator>Thomas A Fischer</dc:creator>
<dc:creator>Tuija Vasankari</dc:creator>
<dc:creator>K E Juhani Airaksinen</dc:creator>
<dc:creator>L Christian Napp</dc:creator>
<dc:creator>Rafal Dworakowski</dc:creator>
<dc:creator>Philip MacCarthy</dc:creator>
<dc:creator>Christoph Kaiser</dc:creator>
<dc:creator>Stefan Osswald</dc:creator>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:creator>Christina Chan</dc:creator>
<dc:creator>Paul Bridgman</dc:creator>
<dc:creator>Daniel Beug</dc:creator>
<dc:creator>Clément Delmas</dc:creator>
<dc:creator>Olivier Lairez</dc:creator>
<dc:creator>Ekaterina Gilyarova</dc:creator>
<dc:creator>Alexandra Shilova</dc:creator>
<dc:creator>Mikhail Gilyarov</dc:creator>
<dc:creator>Ibrahim El-Battrawy</dc:creator>
<dc:creator>Ibrahim Akin</dc:creator>
<dc:creator>Karolina Poledniková</dc:creator>
<dc:creator>Petr Toušek</dc:creator>
<dc:creator>David E Winchester</dc:creator>
<dc:creator>Michael Massoomi</dc:creator>
<dc:creator>Jan Galuszka</dc:creator>
<dc:creator>Christian Ukena</dc:creator>
<dc:creator>Gregor Poglajen</dc:creator>
<dc:creator>Pedro Carrilho-Ferreira</dc:creator>
<dc:creator>Christian Hauck</dc:creator>
<dc:creator>Carla Paolini</dc:creator>
<dc:creator>Claudio Bilato</dc:creator>
<dc:creator>Yoshio Kobayashi</dc:creator>
<dc:creator>Ken Kato</dc:creator>
<dc:creator>Iwao Ishibashi</dc:creator>
<dc:creator>Toshiharu Himi</dc:creator>
<dc:creator>Jehangir Din</dc:creator>
<dc:creator>Ali Al-Shammari</dc:creator>
<dc:creator>Abhiram Prasad</dc:creator>
<dc:creator>Charanjit S Rihal</dc:creator>
<dc:creator>Kan Liu</dc:creator>
<dc:creator>P Christian Schulze</dc:creator>
<dc:creator>Matteo Bianco</dc:creator>
<dc:creator>Lucas Jörg</dc:creator>
<dc:creator>Hans Rickli</dc:creator>
<dc:creator>Gonçalo Pestana</dc:creator>
<dc:creator>Thanh H Nguyen</dc:creator>
<dc:creator>Michael Böhm</dc:creator>
<dc:creator>Lars S Maier</dc:creator>
<dc:creator>Fausto J Pinto</dc:creator>
<dc:creator>Petr Widimský</dc:creator>
<dc:creator>Stephan B Felix</dc:creator>
<dc:creator>Ruediger C Braun-Dullaeus</dc:creator>
<dc:creator>Wolfgang Rottbauer</dc:creator>
<dc:creator>Gerd Hasenfuß</dc:creator>
<dc:creator>Burkert M Pieske</dc:creator>
<dc:creator>Heribert Schunkert</dc:creator>
<dc:creator>Monika Budnik</dc:creator>
<dc:creator>Grzegorz Opolski</dc:creator>
<dc:creator>Holger Thiele</dc:creator>
<dc:creator>Johann Bauersachs</dc:creator>
<dc:creator>John D Horowitz</dc:creator>
<dc:creator>Carlo Di Mario</dc:creator>
<dc:creator>William Kong</dc:creator>
<dc:creator>Mayank Dalakoti</dc:creator>
<dc:creator>Yoichi Imori</dc:creator>
<dc:creator>Thomas Münzel</dc:creator>
<dc:creator>Jeroen J Bax</dc:creator>
<dc:creator>Thomas F Lüscher</dc:creator>
<dc:creator>Filippo Crea</dc:creator>
<dc:creator>Frank Ruschitzka</dc:creator>
<dc:creator>Jelena R Ghadri</dc:creator>
<dc:creator>Christian Templin</dc:creator>
<dc:date>2024-05-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiac biomarkers for diagnosing Takotsubo syndrome</dc:title>
<dc:identifier>pmid:38717630</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae231</dc:identifier>
</item>
<item>
<title>JAMA Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38717512/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 1;9(5). doi: 10.1001/jamacardio.2023.3659.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38717512/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38717512</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.3659>10.1001/jamacardio.2023.3659</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38717512</guid>
<pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-08</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>JAMA Cardiology</dc:title>
<dc:identifier>pmid:38717512</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.3659</dc:identifier>
</item>
<item>
<title>Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38714197/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>Non-hematopoietic cells are essential contributors to hematopoiesis. However, heterogeneity and spatial organization of these cells in human bone marrow remain largely uncharacterized. We used single-cell RNA sequencing (scRNA-seq) to profile 29,325 non-hematopoietic cells and discovered nine transcriptionally distinct subtypes. We simultaneously profiled 53,417 hematopoietic cells and predicted their interactions with non-hematopoietic subsets. We employed co-detection by indexing (CODEX) to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 2:S0092-8674(24)00408-2. doi: 10.1016/j.cell.2024.04.013. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Non-hematopoietic cells are essential contributors to hematopoiesis. However, heterogeneity and spatial organization of these cells in human bone marrow remain largely uncharacterized. We used single-cell RNA sequencing (scRNA-seq) to profile 29,325 non-hematopoietic cells and discovered nine transcriptionally distinct subtypes. We simultaneously profiled 53,417 hematopoietic cells and predicted their interactions with non-hematopoietic subsets. We employed co-detection by indexing (CODEX) to spatially profile over 1.2 million cells. We integrated scRNA-seq and CODEX data to link predicted cellular signaling with spatial proximity. Our analysis revealed a hyperoxygenated arterio-endosteal neighborhood for early myelopoiesis, and an adipocytic localization for early hematopoietic stem and progenitor cells (HSPCs). We used our CODEX atlas to annotate new images and uncovered mesenchymal stromal cell (MSC) expansion and spatial neighborhoods co-enriched for leukemic blasts and MSCs in acute myeloid leukemia (AML) patient samples. This spatially resolved, multiomic atlas of human bone marrow provides a reference for investigation of cellular interactions that drive hematopoiesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38714197/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38714197</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.013>10.1016/j.cell.2024.04.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38714197</guid>
<pubDate>Tue, 07 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Shovik Bandyopadhyay</dc:creator>
<dc:creator>Michael P Duffy</dc:creator>
<dc:creator>Kyung Jin Ahn</dc:creator>
<dc:creator>Jonathan H Sussman</dc:creator>
<dc:creator>Minxing Pang</dc:creator>
<dc:creator>David Smith</dc:creator>
<dc:creator>Gwendolyn Duncan</dc:creator>
<dc:creator>Iris Zhang</dc:creator>
<dc:creator>Jeffrey Huang</dc:creator>
<dc:creator>Yulieh Lin</dc:creator>
<dc:creator>Barbara Xiong</dc:creator>
<dc:creator>Tamjid Imtiaz</dc:creator>
<dc:creator>Chia-Hui Chen</dc:creator>
<dc:creator>Anusha Thadi</dc:creator>
<dc:creator>Changya Chen</dc:creator>
<dc:creator>Jason Xu</dc:creator>
<dc:creator>Melissa Reichart</dc:creator>
<dc:creator>Zachary Martinez</dc:creator>
<dc:creator>Caroline Diorio</dc:creator>
<dc:creator>Chider Chen</dc:creator>
<dc:creator>Vinodh Pillai</dc:creator>
<dc:creator>Oraine Snaith</dc:creator>
<dc:creator>Derek Oldridge</dc:creator>
<dc:creator>Siddharth Bhattacharyya</dc:creator>
<dc:creator>Ivan Maillard</dc:creator>
<dc:creator>Martin Carroll</dc:creator>
<dc:creator>Charles Nelson</dc:creator>
<dc:creator>Ling Qin</dc:creator>
<dc:creator>Kai Tan</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging</dc:title>
<dc:identifier>pmid:38714197</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.013</dc:identifier>
</item>
<item>
<title>Non-traditional risk factors: built environment assessed by Google Street View, syphilis, and rheumatoid arthritis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38713840/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 7;45(17):1489-1493. doi: 10.1093/eurheartj/ehae261.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38713840/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38713840</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae261>10.1093/eurheartj/ehae261</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38713840</guid>
<pubDate>Tue, 07 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Non-traditional risk factors: built environment assessed by Google Street View, syphilis, and rheumatoid arthritis</dc:title>
<dc:identifier>pmid:38713840</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae261</dc:identifier>
</item>
<item>
<title>Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38713839/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 7;45(17):1537-1539. doi: 10.1093/eurheartj/ehae164.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38713839/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38713839</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae164>10.1093/eurheartj/ehae164</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38713839</guid>
<pubDate>Tue, 07 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Sarah Goldstein</dc:creator>
<dc:creator>Kathryn Lindley</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes</dc:title>
<dc:identifier>pmid:38713839</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae164</dc:identifier>
</item>
<item>
<title>Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38712557/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: sFUS causes dose-dependent, sustained improvement of hemodynamic, autonomic, laboratory, and pathological manifestations in 2 models of experimental pulmonary hypertension. Mechanistically, sFUS normalizes immune cell populations in the spleen and downregulates inflammatory genes and pathways in the lung, many of which are relevant in human disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 7. doi: 10.1161/CIRCRESAHA.123.323679. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Inflammation is pathogenically implicated in pulmonary arterial hypertension; however, it has not been adequately targeted therapeutically. We investigated whether neuromodulation of an anti-inflammatory neuroimmune pathway involving the splenic nerve using noninvasive, focused ultrasound stimulation of the spleen (sFUS) can improve experimental pulmonary hypertension.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Pulmonary hypertension was induced in rats either by Sugen 5416 (20 mg/kg SQ) injection, followed by 21 (or 35) days of hypoxia (sugen/hypoxia model), or by monocrotaline (60 mg/kg IP) injection (monocrotaline model). Animals were randomized to receive either 12-minute-long sessions of sFUS daily or sham stimulation for 14 days. Catheterizations, echocardiography, indices of autonomic function, lung and heart histology and immunohistochemistry, spleen flow cytometry, and lung single-cell RNA sequencing were performed after treatment to assess the effects of sFUS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Splenic denervation right before induction of pulmonary hypertension results in a more severe disease phenotype. In both sugen/hypoxia and monocrotaline models, sFUS treatment reduces right ventricular systolic pressure by 25% to 30% compared with sham treatment, without affecting systemic pressure, and improves right ventricular function and autonomic indices. sFUS reduces wall thickness, apoptosis, and proliferation in small pulmonary arterioles, suppresses CD3<sup>+</sup> and CD68<sup>+</sup> cell infiltration in lungs and right ventricular fibrosis and hypertrophy and lowers BNP (brain natriuretic peptide). Beneficial effects persist for weeks after sFUS discontinuation and are more robust with early and longer treatment. Splenic denervation abolishes sFUS therapeutic benefits. sFUS partially normalizes CD68<sup>+</sup> and CD8<sup>+</sup> T-cell counts in the spleen and downregulates several inflammatory genes and pathways in nonclassical and classical monocytes and macrophages in the lung. Differentially expressed genes in those cell types are significantly enriched for human pulmonary arterial hypertension-associated genes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: sFUS causes dose-dependent, sustained improvement of hemodynamic, autonomic, laboratory, and pathological manifestations in 2 models of experimental pulmonary hypertension. Mechanistically, sFUS normalizes immune cell populations in the spleen and downregulates inflammatory genes and pathways in the lung, many of which are relevant in human disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38712557/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38712557</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323679>10.1161/CIRCRESAHA.123.323679</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38712557</guid>
<pubDate>Tue, 07 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Stefanos Zafeiropoulos</dc:creator>
<dc:creator>Umair Ahmed</dc:creator>
<dc:creator>Alexandra Bekiaridou</dc:creator>
<dc:creator>Naveen Jayaprakash</dc:creator>
<dc:creator>Ibrahim T Mughrabi</dc:creator>
<dc:creator>Nafiseh Saleknezhad</dc:creator>
<dc:creator>Chrystal Chadwick</dc:creator>
<dc:creator>Anna Daytz</dc:creator>
<dc:creator>Izumi Kurata-Sato</dc:creator>
<dc:creator>Yemil Atish-Fregoso</dc:creator>
<dc:creator>Kaitlin Carroll</dc:creator>
<dc:creator>Yousef Al-Abed</dc:creator>
<dc:creator>Marat Fudim</dc:creator>
<dc:creator>Christopher Puleo</dc:creator>
<dc:creator>George Giannakoulas</dc:creator>
<dc:creator>Mark Nicolls</dc:creator>
<dc:creator>Betty Diamond</dc:creator>
<dc:creator>Stavros Zanos</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:38712557</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323679</dc:identifier>
</item>
<item>
<title>Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38710772/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>This Perspective article is a form of 'pastiche', inspired by the 1993 review by Lincoff and Topol entitled 'Illusion of reperfusion', and explores how their concept continues to apply to percutaneous revascularization in patients with coronary artery disease and ischaemia. Just as Lincoff and Topol argued that reperfusion of acute myocardial infarction was facing unresolved obstacles that hampered clinical success in 1993, we propose that challenging issues are similarly jeopardizing the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 May 7. doi: 10.1038/s41569-024-01014-0. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This Perspective article is a form of 'pastiche', inspired by the 1993 review by Lincoff and Topol entitled 'Illusion of reperfusion', and explores how their concept continues to apply to percutaneous revascularization in patients with coronary artery disease and ischaemia. Just as Lincoff and Topol argued that reperfusion of acute myocardial infarction was facing unresolved obstacles that hampered clinical success in 1993, we propose that challenging issues are similarly jeopardizing the potential benefits of stent-based angioplasty today. By analysing the appropriateness and efficacy of percutaneous coronary intervention (PCI), we emphasize the limitations of relying solely on visual angiographic guidance, which frequently leads to inappropriate stenting and overtreatment in up to one-third of patients and the associated increased risk of periprocedural myocardial infarction. The lack of optimal revascularization observed in half of patients undergoing PCI confers risks such as suboptimal physiology after PCI, residual angina and long-term stent-related events, leaving an estimated 76% of patients with an 'illusion of revascularization'. These outcomes highlight the need to refine our diagnostic tools by integrating physiological assessments with targeted intracoronary imaging and emerging strategies, such as co-registration systems and angiography-based computational methods enhanced by artificial intelligence, to achieve optimal revascularization outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38710772/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38710772</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01014-0>10.1038/s41569-024-01014-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38710772</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Simone Fezzi</dc:creator>
<dc:creator>Daixin Ding</dc:creator>
<dc:creator>Felix Mahfoud</dc:creator>
<dc:creator>Jiayue Huang</dc:creator>
<dc:creator>Alexandra J Lansky</dc:creator>
<dc:creator>Shengxian Tu</dc:creator>
<dc:creator>William Wijns</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?</dc:title>
<dc:identifier>pmid:38710772</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01014-0</dc:identifier>
</item>
<item>
<title>Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709844/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):e1164. doi: 10.1161/CIR.0000000000001247. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709844/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709844</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001247>10.1161/CIR.0000000000001247</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709844</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association</dc:title>
<dc:identifier>pmid:38709844</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001247</dc:identifier>
</item>
<item>
<title>Unlocking Pathways That Improve Cardiac Function in Chronic Heart Failure: Are Ketones the Key?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709843/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):1490-1492. doi: 10.1161/CIRCULATIONAHA.124.069256. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709843/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709843</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069256>10.1161/CIRCULATIONAHA.124.069256</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709843</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Satyam Sarma</dc:creator>
<dc:creator>Jason R B Dyck</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Unlocking Pathways That Improve Cardiac Function in Chronic Heart Failure: Are Ketones the Key?</dc:title>
<dc:identifier>pmid:38709843</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069256</dc:identifier>
</item>
<item>
<title>Identifying Cardiomyocyte Ploidy With Nuclear Area and Volume</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709842/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):1540-1542. doi: 10.1161/CIRCULATIONAHA.123.065507. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709842/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709842</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065507>10.1161/CIRCULATIONAHA.123.065507</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709842</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Zehao Yao</dc:creator>
<dc:creator>Lina Bai</dc:creator>
<dc:creator>Kefei Dou</dc:creator>
<dc:creator>Yu Nie</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Identifying Cardiomyocyte Ploidy With Nuclear Area and Volume</dc:title>
<dc:identifier>pmid:38709842</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065507</dc:identifier>
</item>
<item>
<title>Will HIV Break the Heart of Africans?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709841/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):1471-1473. doi: 10.1161/CIRCULATIONAHA.123.065836. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709841/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709841</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11076003/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">PMC11076003</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065836>10.1161/CIRCULATIONAHA.123.065836</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709841</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Roger J Bedimo</dc:creator>
<dc:creator>Fiona Strasserking</dc:creator>
<dc:creator>Pablo Tebas</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Will HIV Break the Heart of Africans?</dc:title>
<dc:identifier>pmid:38709841</dc:identifier>
<dc:identifier>pmc:PMC11076003</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065836</dc:identifier>
</item>
<item>
<title>Stroke Science and Care Since the Founding of the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709839/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):1469-1470. doi: 10.1161/CIRCULATIONAHA.123.065471. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709839/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709839</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065471>10.1161/CIRCULATIONAHA.123.065471</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709839</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Mitchell S V Elkind</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Stroke Science and Care Since the Founding of the American Heart Association</dc:title>
<dc:identifier>pmid:38709839</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065471</dc:identifier>
</item>
<item>
<title>Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38709838/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 7;149(19):1536-1539. doi: 10.1161/CIRCULATIONAHA.124.068080. Epub 2024 May 6.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38709838/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38709838</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068080>10.1161/CIRCULATIONAHA.124.068080</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38709838</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Justin T Morrison</dc:creator>
<dc:creator>Mario Enrico Canonico</dc:creator>
<dc:creator>Sonia S Anand</dc:creator>
<dc:creator>Manesh R Patel</dc:creator>
<dc:creator>Eike Sebastian Debus</dc:creator>
<dc:creator>Mark R Nehler</dc:creator>
<dc:creator>Connie N Hess</dc:creator>
<dc:creator>Judith Hsia</dc:creator>
<dc:creator>Warren H Capell</dc:creator>
<dc:creator>Eva Muehlhofer</dc:creator>
<dc:creator>Lloyd P Haskell</dc:creator>
<dc:creator>Scott D Berkowitz</dc:creator>
<dc:creator>Rupert M Bauersachs</dc:creator>
<dc:creator>Marc P Bonaca</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD</dc:title>
<dc:identifier>pmid:38709838</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068080</dc:identifier>
</item>
<item>
<title>Adducin Regulates Sarcomere Disassembly During Cardiomyocyte Mitosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38708635/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results highlight an important mechanism for coordinating cytoskeletal morphological changes during cardiomyocyte mitosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 6. doi: 10.1161/CIRCULATIONAHA.122.059102. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Recent interest in understanding cardiomyocyte cell cycle has been driven by potential therapeutic applications in cardiomyopathy. However, despite recent advances, cardiomyocyte mitosis remains a poorly understood process. For example, it is unclear how sarcomeres are disassembled during mitosis to allow the abscission of daughter cardiomyocytes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Here, we use a proteomics screen to identify adducin, an actin capping protein previously not studied in cardiomyocytes, as a regulator of sarcomere disassembly. We generated many adeno-associated viruses and cardiomyocyte-specific genetic gain-of-function models to examine the role of adducin in neonatal and adult cardiomyocytes in vitro and in vivo.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We identify adducin as a regulator of sarcomere disassembly during mammalian cardiomyocyte mitosis. α/γ-adducins are selectively expressed in neonatal mitotic cardiomyocytes, and their levels decline precipitously thereafter. Cardiomyocyte-specific overexpression of various splice isoforms and phospho-isoforms of α-adducin in identified Thr445/Thr480 phosphorylation of a short isoform of α-adducin as a potent inducer of neonatal cardiomyocyte sarcomere disassembly. Concomitant overexpression of this α-adducin variant along with γ-adducin resulted in stabilization of the adducin complex and persistent sarcomere disassembly in adult mice, which is mediated by interaction with α-actinin.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results highlight an important mechanism for coordinating cytoskeletal morphological changes during cardiomyocyte mitosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38708635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38708635</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.122.059102>10.1161/CIRCULATIONAHA.122.059102</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38708635</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Feng Xiao</dc:creator>
<dc:creator>Ngoc Uyen Nhi Nguyen</dc:creator>
<dc:creator>Ping Wang</dc:creator>
<dc:creator>Shujuan Li</dc:creator>
<dc:creator>Ching-Cheng Hsu</dc:creator>
<dc:creator>Suwannee Thet</dc:creator>
<dc:creator>Wataru Kimura</dc:creator>
<dc:creator>Xiang Luo</dc:creator>
<dc:creator>Nicholas T Lam</dc:creator>
<dc:creator>Ivan Menendez-Montes</dc:creator>
<dc:creator>Waleed Elhelaly</dc:creator>
<dc:creator>Alisson Campos Cardoso</dc:creator>
<dc:creator>Ana Helena Macedo Pereira</dc:creator>
<dc:creator>Rohit Singh</dc:creator>
<dc:creator>Sakthivel Sadayappan</dc:creator>
<dc:creator>Mohammed Kanchwala</dc:creator>
<dc:creator>Chao Xing</dc:creator>
<dc:creator>Feria A Ladha</dc:creator>
<dc:creator>J Travis Hinson</dc:creator>
<dc:creator>Roger J Hajjar</dc:creator>
<dc:creator>Joseph A Hill</dc:creator>
<dc:creator>Hesham A Sadek</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Adducin Regulates Sarcomere Disassembly During Cardiomyocyte Mitosis</dc:title>
<dc:identifier>pmid:38708635</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.122.059102</dc:identifier>
</item>
<item>
<title>Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38708602/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our studies unravel a new role for the transcriptional repressor Hmbox1 in exercise-induced physiological cardiac growth. They also highlight the therapeutic potential of targeting Hmbox1 to improve myocardial survival and glucose metabolism after I/R injury.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 6. doi: 10.1161/CIRCULATIONAHA.123.067592. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Exercise-induced physiological cardiac growth regulators may protect the heart from ischemia/reperfusion (I/R) injury. Homeobox-containing 1 (Hmbox1), a homeobox family member, has been identified as a putative transcriptional repressor and is downregulated in the exercised heart. However, its roles in exercise-induced physiological cardiac growth and its potential protective effects against cardiac I/R injury remain largely unexplored.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We studied the function of Hmbox1 in exercise-induced physiological cardiac growth in mice after 4 weeks of swimming exercise. Hmbox1 expression was then evaluated in human heart samples from deceased patients with myocardial infarction and in the animal cardiac I/R injury model. Its role in cardiac I/R injury was examined in mice with adeno-associated virus 9 (AAV9) vector-mediated Hmbox1 knockdown and in those with cardiac myocyte-specific Hmbox1 ablation. We performed RNA sequencing, promoter prediction, and binding assays and identified glucokinase (Gck) as a downstream effector of Hmbox1. The effects of Hmbox1 together with Gck were examined in cardiomyocytes to evaluate their cell size, proliferation, apoptosis, mitochondrial respiration, and glycolysis. The function of upstream regulator of Hmbox1, ETS1, was investigated through ETS1 overexpression in cardiac I/R mice in vivo.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We demonstrated that Hmbox1 downregulation was required for exercise-induced physiological cardiac growth. Inhibition of Hmbox1 increased cardiomyocyte size in isolated neonatal rat cardiomyocytes and human embryonic stem cell-derived cardiomyocytes but did not affect cardiomyocyte proliferation. Under pathological conditions, Hmbox1 was upregulated in both human and animal postinfarct cardiac tissues. Furthermore, both cardiac myocyte-specific Hmbox1 knockout and AAV9-mediated Hmbox1 knockdown protected against cardiac I/R injury and heart failure. Therapeutic effects were observed when sh-Hmbox1 AAV9 was administered after I/R injury. Inhibition of Hmbox1 activated the Akt/mTOR/P70S6K pathway and transcriptionally upregulated Gck, leading to reduced apoptosis and improved mitochondrial respiration and glycolysis in cardiomyocytes. ETS1 functioned as an upstream negative regulator of Hmbox1 transcription, and its overexpression was protective against cardiac I/R injury.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our studies unravel a new role for the transcriptional repressor Hmbox1 in exercise-induced physiological cardiac growth. They also highlight the therapeutic potential of targeting Hmbox1 to improve myocardial survival and glucose metabolism after I/R injury.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38708602/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38708602</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067592>10.1161/CIRCULATIONAHA.123.067592</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38708602</guid>
<pubDate>Mon, 06 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Yihua Bei</dc:creator>
<dc:creator>Yujiao Zhu</dc:creator>
<dc:creator>Jingwen Zhou</dc:creator>
<dc:creator>Songwei Ai</dc:creator>
<dc:creator>Jianhua Yao</dc:creator>
<dc:creator>Mingming Yin</dc:creator>
<dc:creator>Meiyu Hu</dc:creator>
<dc:creator>Weitong Qi</dc:creator>
<dc:creator>Michail Spanos</dc:creator>
<dc:creator>Lin Li</dc:creator>
<dc:creator>Meng Wei</dc:creator>
<dc:creator>Zhenzhen Huang</dc:creator>
<dc:creator>Juan Gao</dc:creator>
<dc:creator>Chang Liu</dc:creator>
<dc:creator>Petra H van der Kraak</dc:creator>
<dc:creator>Guoping Li</dc:creator>
<dc:creator>Zhiyong Lei</dc:creator>
<dc:creator>Joost P G Sluijter</dc:creator>
<dc:creator>Junjie Xiao</dc:creator>
<dc:date>2024-05-06</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury</dc:title>
<dc:identifier>pmid:38708602</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067592</dc:identifier>
</item>
<item>
<title>Six-vessel fenestrated physician-modiﬁed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38703144/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 4:ehae214. doi: 10.1093/eurheartj/ehae214. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38703144/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38703144</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae214>10.1093/eurheartj/ehae214</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38703144</guid>
<pubDate>Sat, 04 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Wei Liu</dc:creator>
<dc:creator>Chi Cui</dc:creator>
<dc:creator>Bisi Wang</dc:creator>
<dc:date>2024-05-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Six-vessel fenestrated physician-modiﬁed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm</dc:title>
<dc:identifier>pmid:38703144</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae214</dc:identifier>
</item>
<item>
<title>Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38703142/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 4:ehae248. doi: 10.1093/eurheartj/ehae248. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38703142/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38703142</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae248>10.1093/eurheartj/ehae248</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38703142</guid>
<pubDate>Sat, 04 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Massimo Volpe</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2024-05-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease</dc:title>
<dc:identifier>pmid:38703142</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae248</dc:identifier>
</item>
<item>
<title>Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38703139/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240508180802&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 4:ehae242. doi: 10.1093/eurheartj/ehae242. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38703139/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240508180802&v=2.18.0.post9+e462414">38703139</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae242>10.1093/eurheartj/ehae242</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38703139</guid>
<pubDate>Sat, 04 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2024-05-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?</dc:title>
<dc:identifier>pmid:38703139</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae242</dc:identifier>
</item>





























</channel>
</rss>